Physician profile
Nelson Lopez
NPI 1659467108
$663.92
in general payments reported to CMS, 2019-2025
10 companies · $46.22 in 2025
The $46.22 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $286 · 2022: $87.21 · 2023: $35.13 · 2024: $210 · 2025: $46.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $163.39 | 2021 | |
| Zimmer Biomet Holdings, INC. | $138.71 | 2024 | Gps III Platelet Concentration System |
| Radius Health, INC. | $115.30 | 2021-2022 | |
| Amgen INC. | $69.07 | 2021-2024 | Evenity, Prolia |
| Pacira Pharmaceuticals Incorporated | $65.73 | 2024-2025 | Zilretta, Exparel, Iovera |
| Medtronic, INC. | $35.13 | 2023 | Intellis Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $27.93 | 2025 | |
| Alvogen INC | $17.65 | 2022 | |
| Smith+Nephew, INC. | $17.16 | 2021 | |
| Endo Pharmaceuticals INC. | $13.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nelson Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.